UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
VBI VACCINES INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials: |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |
EXPLANATORY NOTE
These Definitive Additional Materials are being filed solely to amend and replace the sample Notice of Internet Availability of Proxy Materials (the “Notice”) previously filed by VBI Vaccines Inc. (the “Company”) with the Securities and Exchange Commission (“SEC”) on May 1, 2023 (the “Original Filing”). The Original Filing reflected an incorrect version of the sample Notice, which (i) featured an outdated Company logo, and (ii) listed the director nominees in Proposal 1 in a different order than the Notice that was mailed or made available to the Company’s shareholders. Please note that a correct version of the Notice was mailed or made available to the Company’s shareholders. These Definitive Additional Materials apply only to the Original Filing.
